ALB and lung cancer: Those predictive models include the Glasgow prognostic score (GPS) based on C-reactive protein (CRP) and an albumin combination, the modified Glasgow Prognostic Score (mGPS), prognostic index (PI) based on CRP and WBC, adverse prognostic factors (AFP) including 5 parameters (leukocytes>10.000 μL, ECOG>1, CA 125>35 U/mL, CYFRA 21–1>3.3 μg/L and presence of metastases), the advanced lung cancer inflammation index (ALI) based on albumin, the neutrophil-lymphocyte ratio, Montreal prognostic score (MPS) including clinical parameters, and the neutrophil-lymphocyte ratio [5]–[10].